心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

县域冠状动脉粥样硬化性心脏病分级诊疗技术方案

2022-02-16 中华人民共和国国家卫生健康委员会 卫健委官网

状动脉粥样硬化性心脏病分级

为贯彻落实《国务院办公厅关于推进分级诊疗制度建设的指导意见》（国办发〔2015〕70号）有关要求，进一步推进分级诊疗相关工作，国家卫生健康委会同国家中医药管理局组织制定了县域冠状动脉粥样硬化性心脏病分

中文标题：

县域冠状动脉粥样硬化性心脏病分级诊疗技术方案

发布机构：

中华人民共和国国家卫生健康委员会

发布日期：

2022-02-16

简要介绍：

为贯彻落实《国务院办公厅关于推进分级诊疗制度建设的指导意见》（国办发〔2015〕70号）有关要求，进一步推进分级诊疗相关工作，国家卫生健康委会同国家中医药管理局组织制定了县域冠状动脉粥样硬化性心脏病分级诊疗技术方案。

相关资料下载：
[AttachmentFileName(sort=1, fileName=县域冠状动脉粥样硬化性心脏病分级诊疗技术方案.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a4c551c0023613fc, title=县域冠状动脉粥样硬化性心脏病分级诊疗技术方案, enTitle=, guiderFrom=卫健委官网, authorId=0, author=, summary=为贯彻落实《国务院办公厅关于推进分级诊疗制度建设的指导意见》（国办发〔2015〕70号）有关要求，进一步推进分级诊疗相关工作，国家卫生健康委会同国家中医药管理局组织制定了县域冠状动脉粥样硬化性心脏病分, cover=https://img.medsci.cn/2022221/1645412772303_5579292.png, journalId=0, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Wed Feb 16 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #484848;">为贯彻落实《国务院办公厅关于推进分级诊疗制度建设的指导意见》（国办发〔2015〕70号）有关要求，进一步推进分级诊疗相关工作，国家卫生健康委会同国家</span><span style="color: #484848;">中医药管理局</span><span style="color: #484848;">组织制</span><span style="color: #484848;">定了县域冠状动脉粥样硬化性心脏病分级诊疗技术方案</span><span style="color: #484848;">。</span></p>, tagList=[TagDto(tagId=123329, tagName=状动脉粥样硬化性心脏病分级)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=35, categoryName=预防公卫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4410, appHits=77, showAppHits=0, pcHits=530, showPcHits=4333, likes=0, shares=11, comments=5, approvalStatus=1, publishedTime=Mon Feb 21 15:04:00 CST 2022, publishedTimeString=2022-02-16, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Mon Feb 21 11:09:46 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 13:42:32 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=县域冠状动脉粥样硬化性心脏病分级诊疗技术方案.pdf)])
县域冠状动脉粥样硬化性心脏病分级诊疗技术方案.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1222964, encodeId=2626122296407, content=<a href='/topic/show?id=98ba30898c7' target=_blank style='color:#2F92EE;'>#冠状动脉粥样硬化#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30898, encryptionId=98ba30898c7, topicName=冠状动脉粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Sat May 28 11:35:12 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210113, encodeId=11921210113e3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66e8108716, createdName=ms5000000188518580, createdTime=Sun Apr 10 19:38:40 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197660, encodeId=7042119e660b7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79a36525401, createdName=ms6000000336797633, createdTime=Sun Feb 27 08:29:07 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196749, encodeId=6f7c1196e49b9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Thu Feb 24 10:51:25 CST 2022, time=2022-02-24, status=1, ipAttribution=)]
    2022-05-28 清风徐来2022

    #冠状动脉粥样硬化#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1222964, encodeId=2626122296407, content=<a href='/topic/show?id=98ba30898c7' target=_blank style='color:#2F92EE;'>#冠状动脉粥样硬化#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30898, encryptionId=98ba30898c7, topicName=冠状动脉粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Sat May 28 11:35:12 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210113, encodeId=11921210113e3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66e8108716, createdName=ms5000000188518580, createdTime=Sun Apr 10 19:38:40 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197660, encodeId=7042119e660b7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79a36525401, createdName=ms6000000336797633, createdTime=Sun Feb 27 08:29:07 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196749, encodeId=6f7c1196e49b9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Thu Feb 24 10:51:25 CST 2022, time=2022-02-24, status=1, ipAttribution=)]
    2022-04-10 ms5000000188518580

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1222964, encodeId=2626122296407, content=<a href='/topic/show?id=98ba30898c7' target=_blank style='color:#2F92EE;'>#冠状动脉粥样硬化#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30898, encryptionId=98ba30898c7, topicName=冠状动脉粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Sat May 28 11:35:12 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210113, encodeId=11921210113e3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66e8108716, createdName=ms5000000188518580, createdTime=Sun Apr 10 19:38:40 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197660, encodeId=7042119e660b7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79a36525401, createdName=ms6000000336797633, createdTime=Sun Feb 27 08:29:07 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196749, encodeId=6f7c1196e49b9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Thu Feb 24 10:51:25 CST 2022, time=2022-02-24, status=1, ipAttribution=)]
    2022-02-27 ms6000000336797633

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1222964, encodeId=2626122296407, content=<a href='/topic/show?id=98ba30898c7' target=_blank style='color:#2F92EE;'>#冠状动脉粥样硬化#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30898, encryptionId=98ba30898c7, topicName=冠状动脉粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Sat May 28 11:35:12 CST 2022, time=2022-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210113, encodeId=11921210113e3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66e8108716, createdName=ms5000000188518580, createdTime=Sun Apr 10 19:38:40 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197660, encodeId=7042119e660b7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79a36525401, createdName=ms6000000336797633, createdTime=Sun Feb 27 08:29:07 CST 2022, time=2022-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196749, encodeId=6f7c1196e49b9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Thu Feb 24 10:51:25 CST 2022, time=2022-02-24, status=1, ipAttribution=)]
    2022-02-24 1881eacd07m

    学习了

    0